Stocks / NASDAQ / Entrada Therapeutics Inc.

Entrada Therapeutics Inc.

Our Opinion

Entrada Therapeutics Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“Entrada’s EEV technology enables the functional intracellular delivery of biologics like thymidine phosphorylase by facilitating improved cellular uptake and efficient endosomal escape. Animal studies with ENTR-501 have demonstrated sustained normalization of toxic metabolites.” Read the following article

Company Description

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Company Website: